Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
Phase 2
Recruiting
- Conditions
- Irritable Bowel Syndrome with Diarrhea
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- CinPhloro Pharma, LLC
- Target Recruit Count
- 450
- Registration Number
- NCT06153420
- Locations
- 🇺🇸
Digestive Health Specialists - Dothan, Dothan, Alabama, United States
🇺🇸Clinical Research Associates, LLC, Huntsville, Alabama, United States
🇺🇸Elite Clinical Studies LLC, Phoenix, Arizona, United States
News
No news found